ABSTRACT
Anal canal cancer is a rare cancer with incidence that continues to rise. This has
been in large part due to increased prevalence of immunosuppressed conditions such
as organ transplantation and human immunodeficiency virus along with transmission
of the human papillomavirus. Identification of high-risk groups and close monitoring
of these groups can help to detect earlier stages of cancer. Chemoradiation therapy
remains the mainstay of treatment with excellent outcomes. Surgery for anal canal
carcinoma remains as a salvage technique for failed chemoradiation or recurrent disease.
KEYWORDS
Epidermoid carcinoma - squamous carcinoma - anal canal
REFERENCES
- 1
Zaleski L, Turiansky G W.
Squamous cell carcinoma of the anal canal.
Cutis.
2010;
85
(3)
143-145
- 2
Bower M, Powles T, Newsom-Davis T et al..
HIV-associated anal cancer: has highly active antiretroviral therapy reduced the incidence
or improved the outcome?.
J Acquir Immune Defic Syndr.
2004;
37
(5)
1563-1565
- 3 National Cancer Institute. Anal Cancer Treatment. Available at: http://www.cancer.gov/cancertopics/pdq/treatment/anal/HealthProfessional Accessed November 7, 2010
- 4
Gervaz P, Buchs N, Morel P.
Diagnosis and management of anal cancer.
Curr Gastroenterol Rep.
2008;
10
(5)
502-506
- 5 Wolf B T, Fleshman J W, Beck D E, Pemberton J H, Wexner S D. The ASCRS Textbook
of Colon and Rectal Surgery. New York: Springer; 2011
- 6
Mendenhall W M, Zlotecki R A, Vauthey J N, Copeland E M.
Squamous cell carcinoma of the anal margin treated with radiotherapy.
Oncology (Williston Park).
1996;
10
(12)
1843-1848
- 7 DeVita V T, Lawrence T S, Rosenberg S A, DePinho R A, Weinberg R A. DeVita, Hellman,
and Rosenberg's Cancer: Principles & Practice of Oncology, Volume 1. Philadelphia:
Lippincott Williams & Wilkins; 2008
- 8 Altekruse S F, Kosary C L, Krapcho M et al, Eds.. SEER Cancer Statistics Review,
1975–2007. Bethesda, MD: National Cancer Institute. Available at: http://seer.cancer.gov/csr/1975_2007/ Accessed November 7, 2010
- 9
Frisch M, Glimelius B, van den Brule A J et al..
Sexually transmitted infection as a cause of anal cancer.
N Engl J Med.
1997;
337
(19)
1350-1358
- 10
Palefsky J M.
Anal human papillomavirus infection and anal cancer in HIV-positive individuals: an
emerging problem.
AIDS.
1994;
8
(3)
283-295
- 11
Piketty C, Darragh T M, Heard I et al..
High prevalence of anal squamous intraepithelial lesions in HIV-positive men despite
the use of highly active antiretroviral therapy.
Sex Transm Dis.
2004;
31
(2)
96-99
- 12
Abramowitz L, Benabderrahmane D, Ravaud P et al..
Anal squamous intraepithelial lesions and condyloma in HIV-infected heterosexual men,
homosexual men and women: prevalence and associated factors.
AIDS.
2007;
21
(11)
1457-1465
- 13
Arends M J, Benton E C, McLaren K M, Stark L A, Hunter J A, Bird C C.
Renal allograft recipients with high susceptibility to cutaneous malignancy have an
increased prevalence of human papillomavirus DNA in skin tumours and a greater risk
of anogenital malignancy.
Br J Cancer.
1997;
75
(5)
722-728
- 14
Hogg M E, Popowich D A, Wang E C, Kiel K D, Stryker S J, Halverson A L.
HIV and anal cancer outcomes: a single institution's experience.
Dis Colon Rectum.
2009;
52
(5)
891-897
- 15
Madkan V K, Cook-Norris R H, Steadman M C, Arora A, Mendoza N, Tyring S K.
The oncogenic potential of human papillomaviruses: a review on the role of host genetics
and environmental cofactors.
Br J Dermatol.
2007;
157
(2)
228-241
- 16
De Vuyst H, Clifford G M, Nascimento M C, Madeleine M M, Franceschi S.
Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial
neoplasia of the vulva, vagina and anus: a meta-analysis.
Int J Cancer.
2009;
124
(7)
1626-1636
- 17
Palefsky J M, Holly E A, Hogeboom C J, Berry J M, Jay N, Darragh T M.
Anal cytology as a screening tool for anal squamous intraepithelial lesions.
J Acquir Immune Defic Syndr Hum Retrovirol.
1997;
14
(5)
415-422
- 18
Cranston R D, Hart S D, Gornbein J A, Hirschowitz S L, Cortina G, Moe A A.
The prevalence, and predictive value, of abnormal anal cytology to diagnose anal dysplasia
in a population of HIV-positive men who have sex with men.
Int J STD AIDS.
2007;
18
(2)
77-80
- 19
Devaraj B, Cosman B C.
Expectant management of anal squamous dysplasia in patients with HIV.
Dis Colon Rectum.
2006;
49
(1)
36-40
- 20
Chang G J, Berry J M, Jay N, Palefsky J M, Welton M L.
Surgical treatment of high-grade anal squamous intraepithelial lesions: a prospective
study.
Dis Colon Rectum.
2002;
45
(4)
453-458
- 21
UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research
.
Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone
versus radiotherapy, 5-fluorouracil, and mitomycin.
Lancet.
1996;
348
(9034)
1049-1054
- 22
Cotter S E, Grigsby P W, Siegel B A et al..
FDG-PET/CT in the evaluation of anal carcinoma.
Int J Radiat Oncol Biol Phys.
2006;
65
(3)
720-725
- 23
Trautmann T G, Zuger J H.
Positron emission tomography for pretreatment staging and posttreatment evaluation
in cancer of the anal canal.
Mol Imaging Biol.
2005;
7
(4)
309-313
- 24
Bilimoria K Y, Bentrem D J, Rock C E, Stewart A K, Ko C Y, Halverson A.
Outcomes and prognostic factors for squamous-cell carcinoma of the anal canal: analysis
of patients from the National Cancer Data Base.
Dis Colon Rectum.
2009;
52
(4)
624-631
- 25
Wieland U, Brockmeyer N H, Weissenborn S J et al..
Imiquimod treatment of anal intraepithelial neoplasia in HIV-positive men.
Arch Dermatol.
2006;
142
(11)
1438-1444
- 26
Kreuter A, Potthoff A, Brockmeyer N H German Competence Network HIV/AIDS et al.
Imiquimod leads to a decrease of human papillomavirus DNA and to a sustained clearance
of anal intraepithelial neoplasia in HIV-infected men.
J Invest Dermatol.
2008;
128
(8)
2078-2083
- 27
Richel O, Wieland U, de Vries H J et al..
Topical 5-fluorouracil treatment of anal intraepithelial neoplasia in human immunodeficiency
virus-positive men.
Br J Dermatol.
2010;
163
(6)
1301-1307
10.1111/j.1365-2133.2010.09982.x
[Epub ahead of print]
- 28
Nigro N D, Seydel H G, Considine B, Vaitkevicius V K, Leichman L, Kinzie J J.
Combined preoperative radiation and chemotherapy for squamous cell carcinoma of the
anal canal.
Cancer.
1983;
51
(10)
1826-1829
- 29
Boman B M, Moertel C G, O'Connell M J et al..
Carcinoma of the anal canal. A clinical and pathologic study of 188 cases.
Cancer.
1984;
54
(1)
114-125
- 30
Dougherty B G, Evans H L.
Carcinoma of the anal canal: a study of 79 cases.
Am J Clin Pathol.
1985;
83
(2)
159-164
- 31
Greenall M J, Quan S H, Urmacher C, DeCosse J J.
Treatment of epidermoid carcinoma of the anal canal.
Surg Gynecol Obstet.
1985;
161
(6)
509-517
- 32
Bartelink H, Roelofsen F, Eschwege F et al..
Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the
treatment of locally advanced anal cancer: results of a phase III randomized trial
of the European Organization for Research and Treatment of Cancer Radiotherapy and
Gastrointestinal Cooperative Groups.
J Clin Oncol.
1997;
15
(5)
2040-2049
- 33
Gunderson L L, Winter K A, Ajani J A et al..
Intergroup RTOG 9811 phase III comparison of chemoradiation with 5-FU and mitomycin
vs 5-FU and cisplatin for anal canal carcinoma: impact on disease-free, overall and
colostomy-free survival.
[abstract]
Int J Radiat Oncol Biol Phys.
2006;
66
A43-S24
- 34
Ajani J A, Winter K A, Gunderson L L et al..
Intergroup RTOG 98–11: a phase III randomized study of 5-fluoruracil (5-FU), mitomycin,
and radiotherapy versus 5-fluorouracil, cisplatin and radiotherapy in carcinoma of
the anal canal.
J Clin Oncol.
2006;
24
A4009
- 35
Provencher S, Oehler C, Lavertu S, Jolicoeur M, Fortin B, Donath D.
Quality of life and tumor control after short split-course chemoradiation for anal
canal carcinoma.
Radiat Oncol.
2010;
5
41
- 36
Doci R, Zucali R, La Monica G et al..
Primary chemoradiation therapy with fluorouracil and cisplatin for cancer of the anus:
results in 35 consecutive patients.
J Clin Oncol.
1996;
14
(12)
3121-3125
- 37
Peiffert D, Seitz J F, Rougier P et al..
Preliminary results of a phase II study of high-dose radiation therapy and neoadjuvant
plus concomitant 5-fluorouracil with CDDP chemotherapy for patients with anal canal
cancer: a French cooperative study.
Ann Oncol.
1997;
8
(6)
575-581
- 38
James R, Wan S, Glynne-Jones R et al..
A randomized trial of chemoradiation using mitomycin or cisplatin, with or without
maintenance cisplatin/5FU on squamous cell carcinoma of the anus (ACT II).
J Clin Oncol.
27
18s
2009;
(suppl; abstr LBA4009)
- 39
Engineer R, Mallik S, Mahantshetty U, Shrivastava S.
Impact of radiation dose on locoregional control and survival on squamous cell carcinoma
of anal canal.
Radiother Oncol.
2010;
95
(3)
283-287
- 40
Ferrigno R, Nakamura R A, Dos Santos Novaes P E et al..
Radiochemotherapy in the conservative treatment of anal canal carcinoma: retrospective
analysis of results and radiation dose effectiveness.
Int J Radiat Oncol Biol Phys.
2005;
61
(4)
1136-1142
- 41
Conroy T, Ducreux M, Lemanski C et al..
Treatment intensification by induction chemotherapy (ICT) and radiation dose escalation
in locally advanced squamous cell anal canal carcinoma (LAAC): definitive analysis
of the intergroup ACCORD 03 trial.
J Clin Oncol.
2009;
27
4033
- 42
Graf R, Wust P, Hildebrandt B et al..
Impact of overall treatment time on local control of anal cancer treated with radiochemotherapy.
Oncology.
2003;
65
(1)
14-22
- 43
Kim J H, Sarani B, Orkin B A et al..
HIV-positive patients with anal carcinoma have poorer treatment tolerance and outcome
than HIV-negative patients.
Dis Colon Rectum.
2001;
44
(10)
1496-1502
- 44
Edelman S, Johnstone P A.
Combined modality therapy for HIV-infected patients with squamous cell carcinoma of
the anus: outcomes and toxicities.
Int J Radiat Oncol Biol Phys.
2006;
66
(1)
206-211
- 45
Oehler-Jänne C, Huguet F, Provencher S et al..
HIV-specific differences in outcome of squamous cell carcinoma of the anal canal:
a multicentric cohort study of HIV-positive patients receiving highly active antiretroviral
therapy.
J Clin Oncol.
2008;
26
(15)
2550-2557
- 46
Wexler A, Berson A M, Goldstone S E et al..
Invasive anal squamous-cell carcinoma in the HIV-positive patient: outcome in the
era of highly active antiretroviral therapy.
Dis Colon Rectum.
2008;
51
(1)
73-81
- 47
Hoffman R, Welton M L, Klencke B, Weinberg V, Krieg R.
The significance of pretreatment CD4 count on the outcome and treatment tolerance
of HIV-positive patients with anal cancer.
Int J Radiat Oncol Biol Phys.
1999;
44
(1)
127-131
- 48
Charnley N, Choudhury A, Chesser P, Cooper R A, Sebag-Montefiore D.
Effective treatment of anal cancer in the elderly with low-dose chemoradiotherapy.
Br J Cancer.
2005;
92
(7)
1221-1225
- 49
Das P, Cantor S B, Parker C L et al..
Long-term quality of life after radiotherapy for the treatment of anal cancer.
Cancer.
2010;
116
(4)
822-829
- 50
Longo W E, Vernava III A M, Wade T P, Coplin M A, Virgo K S, Johnson F E.
Recurrent squamous cell carcinoma of the anal canal. Predictors of initial treatment
failure and results of salvage therapy.
Ann Surg.
1994;
220
(1)
40-49
- 51
Flam M, John M, Pajak T F et al..
Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage
chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of
the anal canal: results of a phase III randomized intergroup study.
J Clin Oncol.
1996;
14
(9)
2527-2539
- 52
Akbari R P, Paty P B, Guillem J G et al..
Oncologic outcomes of salvage surgery for epidermoid carcinoma of the anus initially
managed with combined modality therapy.
Dis Colon Rectum.
2004;
47
(7)
1136-1144
- 53
Allal A S, Laurencet F M, Reymond M A, Kurtz J M, Marti M C.
Effectiveness of surgical salvage therapy for patients with locally uncontrolled anal
carcinoma after sphincter-conserving treatment.
Cancer.
1999;
86
(3)
405-409
- 54
Ellenhorn J D, Enker W E, Quan S H.
Salvage abdominoperineal resection following combined chemotherapy and radiotherapy
for epidermoid carcinoma of the anus.
Ann Surg Oncol.
1994;
1
(2)
105-110
- 55
Mullen J T, Rodriguez-Bigas M A, Chang G J et al..
Results of surgical salvage after failed chemoradiation therapy for epidermoid carcinoma
of the anal canal.
Ann Surg Oncol.
2007;
14
(2)
478-483
- 56
Schiller D E, Cummings B J, Rai S et al..
Outcomes of salvage surgery for squamous cell carcinoma of the anal canal.
Ann Surg Oncol.
2007;
14
(10)
2780-2789
- 57
Clark M A, Hartley A, Geh J I.
Cancer of the anal canal.
Lancet Oncol.
2004;
5
(3)
149-157
- 58
Farid H, O'Connell T X.
Methods to decrease the morbidity of abdominoperineal resection.
Am Surg.
1995;
61
(12)
1061-1064
- 59
Papaconstantinou H T, Bullard K M, Rothenberger D A, Madoff R D.
Salvage abdominoperineal resection after failed Nigro protocol: modest success, major
morbidity.
Colorectal Dis.
2006;
8
(2)
124-129
- 60
Shibata D, Hyland W, Busse P et al..
Immediate reconstruction of the perineal wound with gracilis muscle flaps following
abdominoperineal resection and intraoperative radiation therapy for recurrent carcinoma
of the rectum.
Ann Surg Oncol.
1999;
6
(1)
33-37
- 61
Tei T M, Stolzenburg T, Buntzen S, Laurberg S, Kjeldsen H.
Use of transpelvic rectus abdominis musculocutaneous flap for anal cancer salvage
surgery.
Br J Surg.
2003;
90
(5)
575-580
- 62
Engstrom P F, Arnoletti J P, Benson III A B et al.
NCCN. NCCN clinical practice guidelines in oncology. Anal carcinoma.
J Natl Compr Canc Netw.
2010;
8
(1)
106-120
- 63
Magdeburg B, Fried M, Meyenberger C.
Endoscopic ultrasonography in the diagnosis, staging, and follow-up of anal carcinomas.
Endoscopy.
1999;
31
(5)
359-364
- 64
Martellucci J, Naldini G, Colosimo C, Cionini L, Rossi M.
Accuracy of endoanal ultrasound in the follow-up assessment for squamous cell carcinoma
of the anal canal treated with radiochemotherapy.
Surg Endosc.
2009;
23
(5)
1054-1057
- 65
Lund J A, Sundstrom S H, Haaverstad R, Wibe A, Svinsaas M, Myrvold H E.
Endoanal ultrasound is of little value in follow-up of anal carcinomas.
Dis Colon Rectum.
2004;
47
(6)
839-842
- 66
Koh D M, Dzik-Jurasz A, O'Neill B, Tait D, Husband J E, Brown G.
Pelvic phased-array MR imaging of anal carcinoma before and after chemoradiation.
Br J Radiol.
2008;
81
(962)
91-98
- 67
Mistrangelo M E, Pelosi E, Bellò M et al..
Comparison of positron emission tomography scanning and sentinel node biopsy in the
detection of inguinal node metastases in patients with anal cancer.
Int J Radiat Oncol Biol Phys.
2010;
77
(1)
73-78
Chong S LeeM.D.
Division of Colon and Rectal Surgery, Henry Ford Hospital
2799 W. Grand Blvd., Detroit, MI 48202
Email: clee1@hfhs.org
